tiprankstipranks
Advertisement
Advertisement

VVOS Stock Latest News

Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global
The FlyVivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global
8d ago
VVOS
Vivos Therapeutics Creates New Series A Preferred Stock
PremiumCompany Announcements
Vivos Therapeutics Creates New Series A Preferred Stock
9d ago
8K
VVOS
Vivos Therapeutics says Vida oral appliance improves insomnia in study
PremiumThe Fly
Vivos Therapeutics says Vida oral appliance improves insomnia in study
16d ago
VVOS
Vivos Therapeutics Extends Debt-for-Equity Conversion Timeline
PremiumCompany Announcements
Vivos Therapeutics Extends Debt-for-Equity Conversion Timeline
21d ago
8K
VVOS
Vivos Therapeutics Plans Rights Offering to Existing Shareholders
PremiumCompany Announcements
Vivos Therapeutics Plans Rights Offering to Existing Shareholders
30d ago
8K
VVOS
Vivos Therapeutics Forms AIM Florida Sleep Care Venture
PremiumCompany AnnouncementsVivos Therapeutics Forms AIM Florida Sleep Care Venture
1M ago
8K
VVOS
Vivos Therapeutics intends to file registration statement for rights offering
Premium
The Fly
Vivos Therapeutics intends to file registration statement for rights offering
1M ago
VVOS
Vivos Therapeutics enters pact with South Palm Cardiovascular Associates
Premium
The Fly
Vivos Therapeutics enters pact with South Palm Cardiovascular Associates
1M ago
VVOS
Vivos Therapeutics Restructures Debt to Support Nasdaq Compliance
PremiumCompany Announcements
Vivos Therapeutics Restructures Debt to Support Nasdaq Compliance
1M ago
8K
VVOS
Vivos Therapeutics Balances Rapid Growth With Cash Strain
PremiumCompany Announcements
Vivos Therapeutics Balances Rapid Growth With Cash Strain
2M ago
VVOS
Vivos Therapeutics Earnings Call: Growth Meets Cash Strain
PremiumCompany Announcements
Vivos Therapeutics Earnings Call: Growth Meets Cash Strain
2M ago
VVOS
Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)
PremiumThe Fly
Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)
2M ago
VVOS
Vivos Therapeutics Delays Quarterly Filing
PremiumCompany AnnouncementsVivos Therapeutics Delays Quarterly Filing
2M ago
VVOS
Vivos Therapeutics Faces Nasdaq Listing Compliance Challenges
Premium
Company Announcements
Vivos Therapeutics Faces Nasdaq Listing Compliance Challenges
3M ago
8K
VVOS
Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright
Premium
The Fly
Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright
3M ago
VVOS
Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global
PremiumThe Fly
Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global
3M ago
VVOS
Vivos Therapeutics Balances Growth Hopes With Cash Strain
PremiumCompany Announcements
Vivos Therapeutics Balances Growth Hopes With Cash Strain
3M ago
VVOS
Vivos Therapeutics Completes Private Placement to Bolster Liquidity
PremiumCompany Announcements
Vivos Therapeutics Completes Private Placement to Bolster Liquidity
3M ago
8K
VVOS
Vivos Therapeutics Delays Annual Filing Amid Expansion
PremiumCompany Announcements
Vivos Therapeutics Delays Annual Filing Amid Expansion
4M ago
VVOS
VVOS Earnings this Week: How Will it Perform?
PremiumPre-EarningsVVOS Earnings this Week: How Will it Perform?
4M ago
VVOS
Vivos Therapeutics’ oral medical devices proven to enhance airways
Premium
The Fly
Vivos Therapeutics’ oral medical devices proven to enhance airways
4M ago
VVOS
Vivos Therapeutics files to sell 3.96M shares of common stock for holders
Premium
The Fly
Vivos Therapeutics files to sell 3.96M shares of common stock for holders
5M ago
VVOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >